Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
International Journal of Cancer
|
July 8, 2003
Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer
Linda Perron, Isabelle Bairati, Lynne Moore, et al.
Cancer Causes & Control : CCC
|
July 29, 2004
Antihypertensive drug use and the risk of prostate cancer (Canada)
Linda Perron, Isabelle Bairati, François Harel, et al.
Breast Cancer Research and Treatment
|
January 4, 2021
Association between radiologists' and facilities' characteristics and mammography screening detection of ductal carcinoma in situ
Isabelle Théberge, Nathalie Vandal, Linda Perron, et al.
Breast Cancer Research and Treatment
|
December 20, 2018
The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
Isabelle Théberge, Nathalie Vandal, Marie-Hélène Guertin, et al.
American Journal of Public Health
|
February 8, 2018
Perron et al. Respond
Linda Perron, Marc Simard, Jacques Brisson, et al.
American Journal of Public Health
|
August 18, 2017
Standard Period Life Table Used to Compute the Life Expectancy of Diseased Subpopulations: More Confusing Than Helpful
Linda Perron, Marc Simard, Jacques Brisson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
March 20, 2002
PSA screening and prostate cancer mortality
Linda Perron, Lynne Moore, Isabelle Bairati, et al.
Journal of Medical Screening
|
December 22, 2018
Breast cancer subtype and screening sensitivity in the Quebec Mammography Screening Program
Linda Perron, Sue-Ling Chang, Jean-Marc Daigle, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes
|
February 21, 2018
Clinical Image Quality and Sensitivity in an Organized Mammography Screening Program
Isabelle Théberge, Marie-Hélène Guertin, Nathalie Vandal, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
International Journal of Cancer
|
July 8, 2003
Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer
Linda Perron, Isabelle Bairati, Lynne Moore, et al.
Cancer Causes & Control : CCC
|
July 29, 2004
Antihypertensive drug use and the risk of prostate cancer (Canada)
Linda Perron, Isabelle Bairati, François Harel, et al.
Breast Cancer Research and Treatment
|
January 4, 2021
Association between radiologists' and facilities' characteristics and mammography screening detection of ductal carcinoma in situ
Isabelle Théberge, Nathalie Vandal, Linda Perron, et al.
Breast Cancer Research and Treatment
|
December 20, 2018
The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
Isabelle Théberge, Nathalie Vandal, Marie-Hélène Guertin, et al.
American Journal of Public Health
|
February 8, 2018
Perron et al. Respond
Linda Perron, Marc Simard, Jacques Brisson, et al.
American Journal of Public Health
|
August 18, 2017
Standard Period Life Table Used to Compute the Life Expectancy of Diseased Subpopulations: More Confusing Than Helpful
Linda Perron, Marc Simard, Jacques Brisson, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
March 20, 2002
PSA screening and prostate cancer mortality
Linda Perron, Lynne Moore, Isabelle Bairati, et al.
Journal of Medical Screening
|
December 22, 2018
Breast cancer subtype and screening sensitivity in the Quebec Mammography Screening Program
Linda Perron, Sue-Ling Chang, Jean-Marc Daigle, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes
|
February 21, 2018
Clinical Image Quality and Sensitivity in an Organized Mammography Screening Program
Isabelle Théberge, Marie-Hélène Guertin, Nathalie Vandal, et al.
Page
of 1